BIT
NVO

BlackRock Institutional Trust’s Novo Nordisk NVO Stock Holding History

BlackRock Institutional Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20,280
Closed -$549K – 3930
2016
Q1 		$549K Buy
+20,280
New +$543K ﹤0.01% 3436
2013
Q4 		– Sell
-28,240
Closed -$478K – 4000
2013
Q3 		$478K Buy
+28,240
New +$475K ﹤0.01% 3539

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

BlackRock Institutional Trust's NVO Position: Q2 2016 in Review

BlackRock Institutional Trust sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 20,280 shares — an estimated $549K sold.

BlackRock Institutional Trust first reported a position in NVO in Q3 2013 and held it in 2 quarters. The position peaked at $549K in Q1 2016. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

  • BlackRock Institutional Trust reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 20,280 Novo Nordisk shares in Q2 2016, an estimated $549K.
  • BlackRock Institutional Trust first reported a position in Novo Nordisk in Q3 2013 and held it in 2 quarters.
  • BlackRock Institutional Trust's Novo Nordisk position peaked at $549K in Q1 2016.
  • 530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on BlackRock Institutional Trust's 13F filing for Q2 2016, filed 10 Aug 2016.